Ra Medical Systems was founded in 2002 by Dean Irwin and Melissa Burstein to design, develop, and commercialize excimer lasers for the treatment of dermatologic and cardiovascular diseases. Its flagship product, Pharos, launched in 2004 and revolutionized the dermatology world with its technological advancements and game-changing business model of affordable ownership with unlimited use.
Staying true to the values upon which the company was founded, Ra Medical Systems continued to be a private, clinically-oriented, scientifically-driven organization, focusing on self-funding its growth organically and sustainably. Maintaining profitability year after year by strategic cost management while exponentially growing revenue from Pharos laser sales in the US and internationally, profits were reinvested internally to fund the development of its cardiovascular laser and catheters.
In 2012, the first patients were treated with Ra Medical Systems’ cardiovascular DABRA catheter and laser system in a pilot study conducted outside the United States.
Over the past decade, Pharos has helped hundreds of thousands of patients triumph over difficult-to-treat skin diseases and gain more confidence in their appearance and themselves. Ra Medical Systems’ Pharos has transformed their lives.
Today, Ra Medical Systems continues to make history as it conducts an investigational study of its cardiovascular DABRA catheter and laser system in the Unites States. The company believes this study can support a 510(k) medical device clearance and pave the way for patients all over the world to benefit.
Our Pledge To You
We, Ra Medical Systems, pledge to provide the highest quality, innovative technology that improves patients’ lives. We will do so with honesty and integrity, transparency in our actions, accountability for our products, and mindfulness of our responsibilities to our customers, their patients, and our shareholders.
A Legacy of Innovation
Ra Medical Systems was founded on three fundamental beliefs:
- Excimer laser medicine could save and change lives for the better.
- A totally new kind of company, built differently than those before it, could fulfill its potential.
- The company must merge innovative science with pragmatic entrepreneurship, create a culture of smart, cost-effective decision making and personal accountability, and deliver better, safer, faster, and cheaper lasers and catheters.
This is the company we have built. This is the culture we have created. And this is the mission that drives us forward every day.
Keep Up To Date On Our Advancements
In addition to advancing excimer laser medicine, Ra Medical Systems is committed to keeping physicians, patients, and shareholders up-to-date on the latest news surrounding the growth of our company and industry. Our Newsroom features a resourceful compendium of press releases, videos, interviews, and the latest news about our excimer lasers.
Looking Back on a Decade of Innovation
In 2006, Fox News ran this story on Ra Medical Systems. Our company was only 4 years old then and already making waves as industry leaders. The same innovation that led the way a decade ago still drives us to constantly improve our revolutionary technology.
Ra Medical Systems’ DABRA Begins First Commercial, FDA-Cleared, In-Patient Use
New Orleans, LA—June 1, 2017 (BUSINESS WIRE) Ra Medical Systems, makers of cardiovascular and dermatology catheters and excimer lasers, today announced the commercial launch in the United States of the Company’s groundbreaking DABRA™ System for the treatment of Peripheral Artery Disease. This follows FDA clearance earlier... Read More
FDA Clears Ra Medical’s DABRA Atherectomy System to Treat PAD
May 30, 2017 Ra Medical Systems, Inc. announced that the US Food and Drug Administration has granted market clearance for the company’s DABRA (Destruction of Arteriosclerotic Blockages by laser Radiation Ablation) atherectomy system with catheter for the treatment of peripheral artery disease. In October 2016, the... Read More
Ra Medical Systems Achieves FDA Clearance For Peripheral Artery Disease Treatment
The FDA has granted marketing clearance to Ra Medical Systems for its DABRA System for peripheral artery disease treatment. The device is a catheter and excimer laser system for the treatment of complex and diffuse arterial blockages in the lower vessels. The single-use catheter produces a... Read More
FDA Grants Market Clearance to Ra Medical Systems for New Peripheral Artery Disease Treatment
Media Contacts Caitlin Kasunich / Lisa Lipson KCSA Strategic Communications 212.896.1241 / 508.843.6428 email@example.com / firstname.lastname@example.org Investor Contacts Jeffrey Kraws President, Ra Medical Systems 609.306.2274 email@example.com Game- Changing DABRA System Removes Blockages from Arteries to Save Limbs and Lives CARLSBAD, Calif. – May 30, 2017... Read More
Ra Medical Systems’ DABRA Atherectomy System Launched in Northern Europe
April 12, 2017 Ra Medical Systems, a maker of excimer lasers and catheters for cardiovascular diseases as well as dermatological diseases, and Bo Medical Technologies, a multinational medical device sales and service distributor, recently announced the launch of the DABRA atherectomy system in Europe. In October... Read More